HMG-Co A Reductase Inhibitors in the Treatment of Cardiovascular Diseases: Stabilization of Coronary Artery Plaque

By  

Current Drug Targets, Vol. 3, Iss. 5, 2002-10 ,pp. : 379-385

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical pharmacology Self-Assessment Questionnaire

By  

Clinical Medicine, Vol. 5, Iss. 1, 2005-01 ,pp. : 29-31

Royal College Of Physicians

Access to resources Recommend Favorite

Zotarolimus for the treatment of coronary artery disease: pathophysiology, DES design, clinical evaluation and future perspective

By Brugaletta Salvatore   Burzotta Francesco   Sabaté Manel  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 1047-1058

Informa Healthcare

Access to resources Recommend Favorite

Platelet glycoprotein IIb/IIIa antagonists in clinical trials for the treatment of coronary artery disease

By Salam Amar M   Al Suwaidi Jassim  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1645-1658

Informa Healthcare

Access to resources Recommend Favorite

Revascularization treatment of stable coronary artery disease

By Magro Michael   Garg Scot   Serruys Patrick W  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 195-212

Informa Healthcare

Access to resources Recommend Favorite